We are building a full stack salivary prognostics company to accelerate and lower the cost of non-invasive prognostics. We are based in Europe.
We are building a full stack salivary prognostics company to accelerate and lower the cost of non-invasive prognostics. We are based in Europe.
What they do: Saliva-based biomarker testing platform for athlete performance and recovery
Location: Tulln an der Donau, Niederösterreich, Austria
Founded: June 8, 2021
Team size: Around 17 employees
Analysis speed & scale: 24–48 hour turnaround for 100–125+ biomarkers
Recent funding: Seed round (Aug 2024); prior angel and grant support
Sports performance, recovery, and injury-risk monitoring via biomarker analytics
2021
Bioanalytics / Healthtech / Sports performance
Seed round reported Aug 2024
Seven-figure (reported)
Reported angel investment and an Austrian Life Science grant
| Company |
|---|
 |
 |
 |
 |
 |